Skip to main content

Circulating Tumor Cell Technology Outlook (Revenue, USD Million, 2012 - 2022).

The growth of the circulating tumor cells (CTC) market is influenced by the increasing mortality rate due to cancer, several types of genetic disorders, drastic changes in lifestyle, an increase in smoking-causing disorders, and a rise in consumption of alcohol. Moreover, developments in bioengineering technologies, biomedical imaging, and the rise in demand for preventive medications for different types of cancers are also stimulating the market growth of circulating tumor cells. However, the factors restraining the market growth comprise the significant cost of detection techniques, scarcity of specific biomarkers for the detection of CTCs, reluctance in the adoption of new technologies, and other technical limits.

Download Free Sample  - https://www.millioninsights.com/industry-reports/circulating-tumor-cells-ctc-market/request-sample

The increasing focus of the market players for the introduction of companion diagnostics for cancer and other disorders and the increase in demand for research projects on cancer are a few trends in the circulating tumor cells industry. The circulating tumor cells market is categorized based on technology, application, and geography. Based on technology, the market is divided into CTC Detection, CTC Enrichment, and CTC Analysis. CTC enrichment segment is expected to lead the market owing to high efficiency due to increased functionalities.

Based on application, the circulating tumor cells (CTC) industry is divided into tumorigenesis research, cancer stem cell research, EMT biomarkers development, and others.EMT biomarkers development segment is predicted to hold the maximum share of the market due to advancements in technology. In terms of end-user, the circulating tumor cells (CTC) market is bifurcated into research & academic institutes, hospitals & clinics, and diagnostic centers. The hospitals and clinics segment is expected to hold a larger share of the market due to the increasing preference for efficient treatment offered at hospitals.

Geographically, the CTC industry is segmented as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America, followed by Europe accounted for the larger share of the market due to a large number of market players and mature healthcare infrastructure. Asia-Pacific is also expected to grow considerably in the coming years due to increasing investment and growing technological advancements in the domain.

The prominent players in the circulating tumor cells industry include ApoCell, Advanced Cell Diagnostics, Inc, ClearbridgeBiomedicsPte Ltd, Aviva Biosciences, CynvenioBiosystems, Inc, BioceptInc, MiltenyiBiotec, Menarini Silicon Biosystems, Qiagen, and CreatvMicrotech Inc.

Comments

Popular posts from this blog

Functional Tea Market is expected to boost the growth of the market over the forecast period.

Functional Tea refers to a series of teas that can contribute to bodily functions. In 2019, the market size of Functional Tea is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. Download Request sample copy -  https://www.innovationmarketresearch.com/market-reports/functional-tea-market/request-sample In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Functional Tea. This report studies the global market size of Functional Tea, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia). This study presents the Functional Tea sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sal...

Atherectomy Devices Industry Landscape & Scope Till, 2014 - 2025.

Asia pacific can be a potential market for atherectomy devices since countries such as India and china possess the largest number of cardiac patients with an annual incidence of 7 million strokes. Tobacco consumption is rapidly increasing in south Asian countries in conjunction with economic expansion increasing their risk of artery diseases. Reduction of abdominal obesity through lifestyle measures can improve all components of the metabolic syndrome and likely delay the development of both diabetes and atherosclerosis. Beyond lifestyle intervention, optimal management of risk factors to evidence-based targets is essential. Download Free Sample -  https://www.millioninsights.com/industry-reports/atherectomy-devices-market-size/request-sample High awareness of health problems caused due to change in lifestyle and optimal management of risk factors can improve the metabolic syndrome and likely reduce the development of both diabetes and atherosclerosis and hence reducing the de...

What are the land and construction requirements to start an Adipic Acid (CAS 124-04-9) manufacturing plant?

  Adipic acid or hexanedioic acid is the most important dicarboxylic acid with the formula (CH2)4(COOH)2. It is produced industrially by the oxidation of cyclohexanone and cyclohexanol with nitric acid. Adipic acid is one of the most important monomers, predominantly as a precursor for the production of nylon 66. The analysts forecast the global adipic acid market to exhibit a CAGR of 4.2% during the period 2019-2024. The report covers the present scenario and the growth prospects of the global adipic acid for 2019-2024. To calculate the market size, the report considers the adipic acid sales volume and revenue. Download Free Sample  -  https://www.radiantinsights.com/research/adipic-acid-cas-124-04-9-market/request-sample The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to...